) has been revised to $7.65 / share. This is a decrease of 14.29% from the prior estimate of $8.92 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...

Microbot Medical Inc. (NASDAQ:MBOT – Get Free Report) passed above its two hundred day moving average during trading on Wednesday after the company announced better than expected quarterly earnings.